Fintel reports that on October 28, 2025, Stifel maintained coverage of BioMarin Pharmaceutical (NasdaqGS:BMRN) with a Buy ...

The company's board meeting is also set, which will not only approve the standalone and consolidated earnings but also ...

Currax Pharmaceuticals LLC ("Currax"), a pharmaceutical, company that delivers life-changing medicines to patients with ...

As Merck looks for growth opportunities ahead of Keytruda’s tumble over the patent cliff, the company’s future now looks a ...

Eli Lilly and computing giant Nvidia are teaming up to build a new supercomputer that the pair say will be the most powerful owned and operated by a pharmaceutical company.

Eli Lilly said on Tuesday it was collaborating with Nvidia to build a supercomputer to help with drug discovery and shorten ...

EDP-323 significantly reduced mean viral load AUC by 85% and 87% in the high- and low-dose groups, respectively, compared ...

Vanigent BioPharm has launched Vanitrack, an AI-powered platform that combines compliance and expense management for ...

Synthetic audience testing is here to stay, but its value depends on how it’s done. Resonance Read introduces a more behaviorally precise, evidence-based way forward.

Recruitment of Three Additional Pediatric Patients in Austria and Ireland Achieves Investigator Study TargetCurrent Pediatric Patient in Ongoing Study Has Completely Healed Skin After 9 months of ...

Eli Lilly is partnering with Nvidia to build a supercomputer aimed at accelerating drug discovery. The collaboration aims to expedite medicine development cycles.

Experts say that sectors such as pharma, energy and infra give banks the opportunity to get “hard collateral” (such as land, ...